Stuart Spechler
Baylor University Medical Center at Dallas
Appearances
DateMay 9, 2023BACKGROUND: Barrett’s Esophagus (BE) develops after reflux-mediated injury to distal esophagus and is only known precursor of esophageal adenocarcinoma (EAC), a highly deadly and increasingly prevalent cancer…Presenter
Speakers
Dallas VA Medical Center/University of Texas Southwestern Medical CenterBaylor University Medical Center at DallasBaylor University Medical Center at DallasBaylor University Medical Center and Baylor Scott and White Research Institute- DateMay 9, 2023BACKGROUND: Barrett’s Esophagus (BE) develops after reflux-mediated injury to distal esophagus and is only known precursor of esophageal adenocarcinoma (EAC), a highly deadly and increasingly prevalent cancer…
Presenter
Speakers
Baylor University Medical Center at DallasBaylor University Medical Center and Baylor Scott and White Research Institute - DateMay 9, 2023Concomitant esophageal dysmotility can be present in up to 2/3 of patients with EoE and GERD. Esophageal dysmotility contribute to symptoms in these patients and can be a reason for a suboptimal response to therapy…
Presenter
Baylor University Medical Center at Dallas - DateMay 9, 2023Concomitant esophageal dysmotility can be present in up to 2/3 of patients with EoE and GERD. Esophageal dysmotility contribute to symptoms in these patients and can be a reason for a suboptimal response to therapy…
Presenters
Baylor University Medical Center at DallasUniversity of Southern California, Keck School of Medicine - DateMay 9, 2023Concomitant esophageal dysmotility can be present in up to 2/3 of patients with EoE and GERD. Esophageal dysmotility contribute to symptoms in these patients and can be a reason for a suboptimal response to therapy…
Presenter
Speakers
University of UtahBaylor University Medical Center and Baylor Scott and White Research InstituteBaylor University Medical Center at Dallas - DateMay 20, 2024BACKGROUND: Proton pump inhibitors (PPIs) are the mainstay of therapy for non-erosive reflux disease (NERD). Potassium-competitive acid blockers (PCABs) have more potent and rapid inhibition of gastric acid secretion than PPIs…
Presenter
Yale School of MedicineSpeakers
Baylor University Medical Center at DallasUniversity of California San DiegoWeill Cornell Medical CenterCase Western Reserve University - DateMay 18, 2024INTRODUCTION: Wounding triggers epithelial-mesenchymal plasticity (EMP), a process in which epithelial cells acquire mesenchymal cell features. Some cells undergoing EMP exhibit _both _epithelial and mesenchymal features, and these epi-mesenchymal (E-M) cells are susceptible to cancer initiation…
Presenter
Speakers
Dallas VA Medical Center/University of Texas Southwestern Medical CenterBaylor University Medical Center at DallasBaylor University Medical Center and Baylor Scott and White Research Institute - DateMay 20, 2024INTRODUCTION: EoE is characterized by Th2 inflammation of the esophagus…
Presenter
Speakers
Baylor University Medical Center at DallasBaylor University Medical Center and Baylor Scott and White Research Institute - DateMay 19, 2024BACKGROUND: Peroral endoscopic myotomy (POEM) is a standard treatment option in achalasia. The endoluminal functional lumen imaging probe (FLIP) system utilizes impedance planimetry to measure diameter and distensibility at the esophagogastric junction (EGJ) in real-time…
Presenter
Speakers
Baylor University Medical Center at DallasBaylor University Medical Center - DateMay 21, 2024INTRODUCTION: Societal guidelines require ≥1cm of esophageal intestinal metaplasia (IM) to diagnose Barrett’s esophagus (BE), and discourage endoscopists from biopsying Z-lines with <1cm of variability, primarily because IM in irregular Z-lines (IMIZL) is assumed to have negligible risk for cancer…
Speakers
Presenter
Baylor University Medical Center and Baylor Scott and White Research Institute 
DateMay 3, 2025SOCIETY: AGAModerator
Baylor University Medical Center at Dallas
